TLPH
TALPHERA, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.08
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 31.35x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.89x
- Price / sales
- —
- Price / cash flow
- -4.57x
Enterprise value
- Enterprise value
- $39.0M
- EV / sales
- —
- EV / EBITDA
- -2.76x
- EV / EBIT
- -2.64x
- Market cap
- $56.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026